HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome.

Abstract
The pahrmacokinetics of paracetamol after intravenous and oral administration has been studied in 6 patients with Gilbert's syndrome, and 6 healthy controls. Paracetamol clearance was significantly less in the patients (255 ml/min SE +/- 23 ml/min) than in the normal subjects (352 ml/min SE +/- 40 ml/min). Moreover, whilst paracetamol concentrations declined monoexponentially in the patients, the decline was biexponential in the controls. No difference in the bioavailability of 500 mg paracetamol given orally was observed between the two groups. The results suggest that not only is paracetamol elimination impaired in Gilbert's syndrome, but that its distribution kinetics are also abnormal. Both these findings could be attributed to a decrease in hepatic glucuronyl transferase activity.
AuthorsA P Douglas, R L Savage, M D Rawlins
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 13 Issue 3 Pg. 209-12 (May 31 1978) ISSN: 0031-6970 [Print] Germany
PMID668775 (Publication Type: Journal Article)
Chemical References
  • Acetaminophen
Topics
  • Acetaminophen (blood, metabolism)
  • Adolescent
  • Adult
  • Female
  • Gilbert Disease (metabolism)
  • Half-Life
  • Humans
  • Hyperbilirubinemia, Hereditary (metabolism)
  • Kinetics
  • Male
  • Middle Aged
  • Models, Biological

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: